期刊文献+

肝癌细胞中STAT3及c-myc的表达及其意义 被引量:6

The expressions of STAT3 and c-myc in hepatocellular carcinoma and their significance
下载PDF
导出
摘要 目的:探讨STAT3及c-myc在肝癌细胞SMMC-7721中的表达,观察抗体干预对细胞增殖和凋亡的影响以及二者的相互关系。方法:免疫细胞化学及RT-PCR观察STAT3及c-myc在肝癌细胞中的表达;抗体干预后,MTT法检测细胞增殖,FCM检测细胞凋亡,RT-PCR检测STAT3及c-myc mRNA表达的变化。结果:STAT3及c-myc在肝癌细胞SMMC-7721中均有表达,单独应用STAT3或c-myc抗体以及联合应用2种抗体对细胞的增殖、凋亡均有影响,在48 h处理组,联合应用抗体的作用更明显。应用STAT3抗体作用于细胞,RT-PCR检测显示c-myc mRNA的表达下降,联合应用抗体后c-myc mRNA的表达明显降低。结论:肝癌细胞SMMC-7721中存在STAT3及c-myc信号通路,STAT3通过上调c-myc而抑制肝癌细胞的凋亡并促进其增殖,二者在肝癌的发生、发展中起重要作用。 Objective: To investigate the expressions of STA73 ( signal transducers and activators of transcription 3 ) and c-myc gene in hepatocellular carcinoma SMMC-7721 cells, observe the effects of antibody interference on cell proliferation and apoptosis, and analyze the correlation of the two genes. Methods: The protein and mRNA expressions of STAT3 and c-myc in SMMC-7721 cells were detected by immunocytochemical method and semi-quantitative RT-PCR, respectively. After antibody interference, cell proliferation was assessed by MTT assay ; apoptosis was detected by flow cytometry ; the mRNA expressions of STAT3 and c-myc were determined by RT- PCR. Results: Both STAT3 and c-myc were expressed in hepatocellular carcinoma SMMC-7721 cells. Immunocytochemical analysis showed that STAT3 and c-myc proteins were mainly localized in the cytoplasm. Proliferation and apoptosis of SMMC-7721 cells were inhibited by treatment with anti-STAT3 antibody and anti-c-myc antibody alone or in combination. The inhibitory effect was more significant for combined therapy group at 48 h. RT-PCR demonstrated that c-myc mRNA expression had significantly decreased after treatment with anti- STAT3 antibody alone and it further decreased after combined treatment. Conclusion:Our findings demonstrated that STAT3 and c-myc signaling pathway exists in SMMC-7721 cell line. STAT3 inhibites the apoptosis and facilitates the proliferation of SMMC-7721 cells by upregulating c-myc expression. STAT3 and c-myc play a critical role in the initiation and progression of hepatocellular carcinoma.
出处 《肿瘤》 CAS CSCD 北大核心 2008年第5期394-397,共4页 Tumor
关键词 肝肿瘤 基因表达 细胞凋亡 细胞 SMMC-7721 Liver neoplasms Gene expression Apoptosis Cell, SMMC-7721
  • 相关文献

参考文献10

  • 1KOTHA A,SEKHARAM M,CILENTI L,et al. Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein [ J ]. Mol Cancer Ther, 2006,5 (3) :621 -629.
  • 2HSIEH FC,CHENG G,LIN J,et al. Evaluation of potential Stat3- regulated genes in human breast cancer[ J ]. Biochem Biophys Res Commun ,2005, 335 (2) :292-299.
  • 3YU H, JOVE R. The STATs of cancer-new molecular targets come of age[J]. Nat Rev Cancer, 2004, 4(2): 97-105.
  • 4SANCHEZ-CKIA S G, REYES-MALDONADO E, VAZQUEZ- MANRIQUEZ M E, et al. Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma[J]. Lung Cancer, 2006, 54(2) :163- 168.
  • 5BARRE B,VIGNERON A,COQUERET O. The STAT3 transcription factor is a target for the Myc and riboblastoma proteins on the Cdc25A promoter[ J]. Biol Chem,2005,280(16) :15673-15681.
  • 6LEVY D E, LEE C K. What does STAT3 do? [ J ]. Clin Invest, 2002,109(9) :1143-1148.
  • 7JING N, TWEARDY D J. Targeting Stat 3 in cancer therapy [ J ]. Anti Cancer Drugs,2005,16(6): 601-607.
  • 8FRANK D A. STAT3 as a central mediator of neoplastic cellular transformation[ J]. Cancer Lett,2007, 251 (2) : 199-210.
  • 9PATEL J H, MCMAHON S B. BCL2 is a downstream effector of MIZ-1 essential for blocking c-myc-induced apoptosis [ J]. Biol Chem,2007, 282( 1 ) : 5-13.
  • 10WU C H, RIGGELEN J, YETIL A, et al. Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation[J]. PNAS,2007,104(32) :13028-13033.

同被引文献37

  • 1潘奇,王鲁,孙惠川,刘银坤,叶胜龙,汤钊猷.不同转移潜能人肝癌细胞系转录因子活性差异分析[J].中华肝脏病杂志,2006,14(1):37-40. 被引量:21
  • 2刘俊茹,王原,左连富,李凤林,王莹,刘嘉琳.COX-2、p-Stat3及p-Stat5在食管癌组织中的表达及其意义[J].癌症,2007,26(5):458-462. 被引量:26
  • 3WEERASINGHE P,GARCIA GE,ZHU Q,et al.Inhibitionof Stat3 activation and tumor growth suppression of non-smallcell lung cancer by G-quartet oligonucleotides[J].Int J Oncol,2007,31(1):129-136.
  • 4GAO B.Hepatoprotective and anti-inflammatory cytokines inalcoholic liver disease[J].J Gastroenterol Hepatol,2012,2(27):89-93.
  • 5LU XL,HE SX,REN MD,et al.Chemopreventive effect ofsaikosaponin-d on diethyl nitrosamine-induced hepatocarcino-genesis:involvement of CCAAT/enhancer binding proteinβand cyclooxygenase-2[J].Mol Med Report,2012,5(3):637-644.
  • 6Chen M,Therneau T,Orsini LS,et al.Design and rationale of the HCC BRIDGE study in China:a longitudinal,multicenter cohort trial in hepatocellular carcinoma[J].BMC Gastroenterol,2011,11:53.
  • 7Wei RC,Cao X,Gui JH,et al.Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma[J].Hum Gene Ther,2011,22(9):1109-1119.
  • 8Wang XH,Meng XW,Xing H,et al.STAT3 and beta-catenin signaling pathway may affect GSK-3 beta expression in hepatocellular carcinoma[J].Hepatogastroenterology,2011,58 (106):487-491.
  • 9Chen J,Yin J,Tan X,et al.Improved multiplex-PCR to identify hepatitis B virus genotypes A-F and subgenotypes B1,B2,C1 and C2[J].J Clin Virol,2007,38(3):238-243.
  • 10Xie J,Zhang Y,Zhang Q,et al.Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma[J].Hepatology,2013,57(6):2369-2377.

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部